CVS Health (CVS) Beats Estimates with 6.3%处方 Growth Despite Q4 Profit Decline

CVS Health (CVS) beat Wall Street estimates for the fourth quarter despite a per-share profit decline, driven by 6.3% growth in prescriptions and the acquisition of Rite Aid assets. Adjusted profit fell to $1.09 vs. $1.19, but exceeded the 99 cents per share average. Total revenue rose to $105.7B from $97.7B, with Health Services revenue reaching $51.2B from $47B. The Inflation Reduction Act raised medical loss ratios and Medicare Advantage costs, while lower-than-expected 2027 payment rate proposals pressured shares. The company reaffirmed its 2026 full-year adjusted EPS guidance of $7.00–$7.20 per share.